Robustness evaluation of pencil beam scanning proton therapy treatment planning: A systematic review.

Proton therapy Protontherapy Robust planning Robustness Robustness analysis Robustness evaluation Treatment planning guidelines

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
01 Jun 2024
Historique:
received: 09 08 2023
revised: 30 04 2024
accepted: 29 05 2024
medline: 4 6 2024
pubmed: 4 6 2024
entrez: 3 6 2024
Statut: aheadofprint

Résumé

Compared to conventional radiotherapy using X-rays, proton therapy, in principle, allows better conformity of the dose distribution to target volumes, at the cost of greater sensitivity to physical, anatomical, and positioning uncertainties. Robust planning, both in terms of plan optimization and evaluation, has gained high visibility in publications on the subject and is part of clinical practice in many centers. However, there is currently no consensus on the methods and parameters to be used for robust optimization or robustness evaluation. We propose to overcome this deficiency by following the modified Delphi consensus method. This method first requires a systematic review of the literature. We performed this review using the PubMed and Web Of Science databases, via two different experts. Potential conflicts were resolved by a third expert. We then explored the different methods before focusing on clinical studies that evaluate robustness on a significant number of patients. Many robustness assessment methods are proposed in the literature. Some are more successful than others and their implementation varies between centers. Moreover, they are not all statistically or mathematically equivalent. The most sophisticated and rigorous methods have seen more limited application due to the difficulty of their implementation and their lack of widespread availability.

Identifiants

pubmed: 38830538
pii: S0167-8140(24)00635-2
doi: 10.1016/j.radonc.2024.110365
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

110365

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Edmond Sterpin is involved in collaborations with Ion Beam Applications and RaySearch laboratories. Erik Korevaar is involved in collaborations with Ion Beam Applications and RaySearch laboratories. Mischa Hoogeman is involved in collaborations with RaySearch laboratories, Varian, Siemens, Accuray, and Elekta.

Auteurs

E Sterpin (E)

KU Leuven - Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium; Université catholique de Louvain - Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), Brussels, Belgium; Particle Therapy Interuniversity Center Leuven - PARTICLE, Leuven, Belgium. Electronic address: edmond.sterpin@kuleuven.be.

L Widesott (L)

Proton Therapy Center - UO Fisica Sanitaria, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy.

K Poels (K)

Particle Therapy Interuniversity Center Leuven - PARTICLE, Leuven, Belgium; UZ Leuven, Department of Radiation Oncology, Leuven, Belgium.

M Hoogeman (M)

Erasmus Medical Center, Cancer Institute, Department of Radiotherapy, Rotterdam, the Netherlands; HollandPTC, Delft, the Netherlands.

E W Korevaar (EW)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.

M Lowe (M)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.

S Molinelli (S)

Fondazione CNAO - Medical Physics Unit, Pavia, Italy.

F Fracchiolla (F)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.

Classifications MeSH